1.390
-0.010
(-0.71%)
At close: January 28 at 11:34:08 AM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-398,418.000
-398,418.000
-536,722.000
-561,198.000
-261,005.000
Investing Cash Flow
9,904.000
9,904.000
-124,083.000
-137,130.000
-91,909.000
Financing Cash Flow
275.000
275.000
112,354.000
-30,621.000
2,859,427.000
End Cash Position
1,005,909.000
1,005,909.000
1,383,336.000
1,834,399.000
2,630,598.000
Capital Expenditure
-14,580.000
-14,580.000
-100,583.000
-137,130.000
-137,217.000
Issuance of Capital Stock
27.000
27.000
94.000
697.000
2,849,341.000
Issuance of Debt
210,000.000
210,000.000
234,800.000
--
49,177.000
Repayment of Debt
-182,300.000
-182,300.000
-100,000.000
--
--
Free Cash Flow
-412,998.000
-412,998.000
-637,305.000
-698,328.000
-398,222.000
12/31/2020 - 11/3/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
2162.HK Keymed Biosciences Inc.
29.500
-2.48%
2137.HK Brii Biosciences Limited
1.120
-0.88%
1952.HK Everest Medicines Limited
40.300
-0.86%
ESLA Estrella Immunopharma, Inc.
1.1723
+3.74%
2142.HK HBM Holdings Limited
3.660
+3.68%
1672.HK ASCLETIS-B
4.050
-0.74%
ASPHF Ascentage Pharma Group International
2.6900
0.00%
1801.HK INNOVENT BIO
33.050
+0.15%
9926.HK Akeso, Inc.
60.850
+1.76%
CRGX CARGO Therapeutics, Inc.
13.19
-3.37%